Ameritox® to Build New Processing Facility in Greensboro, North Carolina

Second laboratory to Support Growth of Nation’s Leader in Pain Medication Monitoring Solutions
October 20, 2009

Baltimore, Maryland (October 20, 2009) – Ameritox, the U.S. leader in pain medication monitoring solutions, today announced plans to build a second laboratory facility in Greensboro, North Carolina.

Ameritox, which provides laboratory services and practice management tools to help clinicians coordinate the care of their chronic pain patients, is scheduled to open the Greensboro facility in 2010.  The Ameritox Greensboro Laboratory will offer the increased processing capacity to match the company’s rapid growth and its commitment to helping physicians monitor patients and enhance treatment outcomes.  Ameritox currently operates a laboratory in Midland, Texas, which performs screening and confirmatory testing on hundreds of thousands of specimens annually through its proprietary Rx GuardianSM methodology.

“We are very excited about locating our laboratory in Greensboro, North Carolina. The state offers a diverse and talented work force, an abundance of top tier educational institutions, and is well situated to help our company continue to grow”, said Ancelmo E. Lopes, Chief Executive Officer of Ameritox.  “Its opening will help us provide more physicians and patients with laboratory information that goes beyond standard urine drug testing to help them determine if patients are taking their medications as directed – ultimately leading to enhanced patient care.”

Ameritox plans to hire 228 employees once the laboratory is fully operational in 2010.

About Ameritox
Ameritox is the nation’s leader in pain medication monitoring solutions, offering specialized laboratory testing and reporting services. Ameritox’s expertise and innovative science provides physicians with insights and support to enhance and optimize the care of chronic pain patients. Ameritox offers Rx GuardianSM, the most thorough and personalized lab service available for monitoring patients on chronic opioid therapy. Medication monitoring helps physicians make more informed clinical decisions and manage the risks and complexities associated with prescribing pain medications. Ameritox is headquartered in Baltimore, MD with laboratory facilities in Midland, TX and Greensboro, NC.

© 2011, Ameritox, Ltd. All rights reserved. AMERITOX, the AMERITOX logos, PAIN MEDICATION MONITORING SOLUTIONS, AMERITOX MEDICATION MONITORING SOLUTIONS, Rx GUARDIAN AUTOREMINDER, Rx GUARDIAN and PROTECT YOUR PATIENTS, PROTECT YOUR PRACTICE, are trademarks of Ameritox. All other trademarks are the claimed trademarks of others.